Vyne Therapeutics
formerly VYNEIPORooted in Innovation
United States · Founded 2011 · $88.2M raised
- Founded
- 2011
- Business Model
- B2B
- Website
- vynetherapeutics.com
- Total Funding
- $88.2M
- Last Round
- $88.2M Corporate RoundNov 2023
- Rounds
- 1
About
VYNE Therapeutics is a clinical-stage biopharmaceutical company developing therapies for inflammatory and immune-mediated diseases.
Summary
Vyne Therapeutics is a Biotech company based in United States, founded in 2011. It has raised $88.2M in total across 1 round, most recently a $88.2M Corporate Round round in Nov 2023. Investors include Access Industries.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2023
Sign up to see all 2 rounds
IPO through Corporate Round — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/vyne-therapeutics"><img src="https://indexed.vc/api/badge/company/vyne-therapeutics" alt="Vyne Therapeutics on Indexed.vc" width="260" height="76" /></a>